ER2 Frailty Levels and Incident Adverse Health Events in Older Community Dwellers
NCT ID: NCT04431986
Last Updated: 2020-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1741 participants
OBSERVATIONAL
2020-09-01
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emergency Room Visits and Older Patients (ER2)
NCT03633240
Risk for Short-term Adverse Events in Older Emergency Department Users
NCT03964311
Association of Centre of Excellence Self-Administered Questionnaire (CESAM) Score and Frailty Levels
NCT03962972
Identification of Frailty Predictors of Adverse Health Outcomes in Community-dwelling Individuals Aged 50 and Over
NCT04603144
Emergency Room Evaluation and Recommendations for Older Users of Emergency Departments
NCT04022551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NuAge participants
All Individuals of the NuAge study who agreed to be part of the NuAge Database for future research purposes
No intervention: secondary use of a database
Statistical analyses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention: secondary use of a database
Statistical analyses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Participants' refusal to use their data for a purpose not identified during their recruitment.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jewish General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cyrille Launay
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cyrille Launay, MD
Role: PRINCIPAL_INVESTIGATOR
Jewish General Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-2432
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.